Further, the downstream regulator of GPX4, i.e., SECISBP2 (Selenocysteine Insertion Sequence-Binding Protein 2), which regulates various selenoproteins, was revealed as a novel prognostic predictor of DLBC lymphomas and may serve as a potential therapeutic target [54]. The gene discussed is SECISBP2; the disease is lymphoma.